-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Sangamo Therapeutics, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
- Sangamo Therapeutics, Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $3.07M, a 54.9% decline year-over-year.
- Sangamo Therapeutics, Inc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $18.1M, a 41.9% decline year-over-year.
- Sangamo Therapeutics, Inc annual Share-based Payment Arrangement, Expense for 2023 was $27.4M, a 13.5% decline from 2022.
- Sangamo Therapeutics, Inc annual Share-based Payment Arrangement, Expense for 2022 was $31.7M, a 3.96% decline from 2021.
- Sangamo Therapeutics, Inc annual Share-based Payment Arrangement, Expense for 2021 was $33M, a 28.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)